CNR Institutional Research Information System

RASI, GUIDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.572
NA - Nord America 1.162
SA - Sud America 300
EU - Europa 259
AF - Africa 24
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 1
Totale 3.324
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.121
SG - Singapore 623
CN - Cina 360
BR - Brasile 244
VN - Vietnam 188
HK - Hong Kong 132
FR - Francia 83
IT - Italia 61
KR - Corea 60
JP - Giappone 59
BD - Bangladesh 39
DE - Germania 25
IN - India 24
NL - Olanda 23
GB - Regno Unito 21
ID - Indonesia 19
CA - Canada 17
CO - Colombia 15
AR - Argentina 10
IL - Israele 10
ZA - Sudafrica 10
EC - Ecuador 9
CL - Cile 8
MX - Messico 8
MY - Malesia 8
TR - Turchia 8
FI - Finlandia 7
IQ - Iraq 7
PY - Paraguay 6
UA - Ucraina 6
EG - Egitto 5
PK - Pakistan 5
SA - Arabia Saudita 5
AT - Austria 4
ES - Italia 4
KZ - Kazakistan 4
PL - Polonia 4
UZ - Uzbekistan 4
VE - Venezuela 4
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
RO - Romania 3
RU - Federazione Russa 3
SE - Svezia 3
BH - Bahrain 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
GE - Georgia 2
IE - Irlanda 2
LB - Libano 2
MA - Marocco 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AG - Antigua e Barbuda 1
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GT - Guatemala 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MM - Myanmar 1
NI - Nicaragua 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 3.318
Salva come PNG Salva come JPEG
Città #
Santa Clara 530
Singapore 353
Hefei 138
Hong Kong 132
Beijing 92
San Jose 79
Lauterbourg 69
Ho Chi Minh City 66
Ashburn 64
Seoul 59
Tokyo 50
Hanoi 39
Los Angeles 26
Guangzhou 20
New York 20
Rome 14
Atlanta 13
Frankfurt am Main 11
Buffalo 10
Rio de Janeiro 10
São Paulo 10
Dallas 9
Minamishinagawa 9
Orem 9
Curitiba 7
Düsseldorf 7
Helsinki 7
Bengaluru 6
Brasília 6
Council Bluffs 6
London 6
Philadelphia 6
Shanghai 6
Thái Bình 6
Charlotte 5
Da Nang 5
Denver 5
Istanbul 5
Milan 5
Orangeburg 5
Augusta 4
Bogotá 4
Everett 4
Guayaquil 4
Hải Dương 4
Johannesburg 4
Miami 4
Montreal 4
New Delhi 4
Salvador 4
Santo André 4
Trento 4
Vienna 4
Warsaw 4
Baghdad 3
Boardman 3
Boston 3
Brooklyn 3
Cairo 3
Can Tho 3
Dhaka 3
Haiphong 3
Houston 3
Jeddah 3
Katy 3
Kuala Lumpur 3
Kyiv 3
Las Vegas 3
Louisville 3
Moscow 3
Mumbai 3
Newark 3
Paraíba do Sul 3
Petaling Jaya 3
Phủ Lý 3
Poplar 3
Quito 3
Sóc Trăng 3
Tashkent 3
Tegucigalpa 3
Thái Nguyên 3
Algiers 2
Almaty 2
Amboy 2
Amsterdam 2
Arapiraca 2
Barranquilla 2
Belo Horizonte 2
Belém 2
Betim 2
Bragança Paulista 2
Buenos Aires 2
Bình Dương 2
Cachoeirinha 2
Cape Town 2
Catalão 2
Centurion 2
Chicago 2
Columbia 2
Columbus 2
Totale 2.100
Salva come PNG Salva come JPEG
Nome #
Ruolo di nuovi marcatori biomolecolari dell'epatocarcinoma su cirrosi, in relazione all'efficacia dei diversi approcci terapeutici. 88
Sviluppo di un protocollo preclinico di immunizzazione genetica verso un antigene tumore-associato del colon 68
PACAP and VIP prevent apoptosis in schwannoma cells 68
Le soluzioni di oggi e le opportunità per il futuro . 66
Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: Transgene expression, immunity and safety 65
Development and application of innovative in vitro/in vivo models for the evaluation of new diagnostic and/or therapeutic approaches of human cancer with particular focus on cancer vaccines 64
AQUA: Allergy Questionnaire for Athletes. Development and validation 64
Need for Redesigning Pharmacologic Research in Older Individuals. A Position Statement of the Geriatric Working Group of the Agenzia Italiana del Farmaco (AIFA) 64
Nerve Growth Factor (NGF) involvement in liver cirrhosis and hepatocellular carcinoma. 60
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN. 59
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 55
Risposta immunitaria dell'ospite eventi cellulari e variabilità virale nell'infezione da HCV . 54
PHYSICAL EXERCISE AS A DETERMINANT OF THE IMMUNE AND ALLERGIC RESPONSE 52
Predictive value of allergy and pulmonary function tests for the diagnosis of asthma in elite athletes. 52
Conjunctival expression of thymosin-â4 in vernal keratoconjunctivitis. 51
Rapporto ospite/Microrganismo risposta immunitaria. 50
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 49
Atrial Natriuretic peptide inhibits colorectal cancer cell growth by reverting the WNT/beta catenin pathway 48
Time to market and patient access to new oncology products in Italy: a multistep pathway from European context to regional health care providers 46
Ricerca e sviluppo di nuovi agenti per l immunoterapia dei tumori attraverso studi di gnomica, proteomica, immunoproteomica e bioinformatica 45
Development of immunoisolated cells implants for locoregional therapy in a colorectal cancer preclinical model 45
PREVENTIVE PEPTIDE VACCINE FOR COLORECTAL CANCER METASTASES. 44
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 44
A new human tumor-associated antigen (TLP) is naturally expressed in rat DHD-K12 colorectal tumor cells. 44
Combination low-dose lymphoblastoid interferon and thymosin alpha 1 therapy in the treatment of chronic hepatitis B. 43
Nanosized cancer polymarker biochip - Laboratorio per la progettazione, produzione e validazione di biosensori optoe chemo-elettronici dedicati al rilevamento simultaneo di biomarkers associati a patologie tumorali 43
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1. 42
L evoluzione nel farmaceutico:verso nuovi scenari di innovazione dei prodotti, efficienza dei processi e sviluppo regolatorio 42
Montelukast, a leukotriene receptor antagonist, in Vernal Keratoconjunctivitis associated with Asthma 42
Nerve Growth Factor (NGF): a possible marker for hepatocellular carcinoma (HCC)? 40
Comparative cellular signal pathway analysis of metastatic colorectal cancer in human and preclinical animal model 40
Up-regulation of melanocytic differentiation antigens induced by Cyanidin-3-O-beta-Glucopyranoside in human melanoma cells. 38
Impact of the Gut Microflora on the development of Allergy 38
Differentiation therapy: in vitro evidence making cyanidin-3-o-beta useful for prevention and treatment of melanoma 38
Cytoplasmic localization of anthracycline antitumor drugs conjugated with reduced glutathione: a possible correlation with multidrug resistance mechanisms 37
Nerve Growth Factor Regulates The Production of Lung Mucins in a Transgenic Mice Model of Asthma. 37
Nuovi scenari della ricerca biomedica in Italia 37
Therapeutic Strategies for HBV/HCV Relapse: The Role Of Thymalfasin 36
Combination thymosin alpha 1 and lymphoblastoid interferon treatment in chronic hepatitis C. 36
Thymosin-a in HCV Hepatitis. Evidence-based medicine 36
Autoimmune Hepatitis 36
Le Epatiti virali croniche: problemi di prevenzione e terapia in Puglia nella nuova realtà delle immigrazioni di massa 36
Combination therapy in the treatment of chronic viral hepatitis 35
Translational aspects in oncology: perspectives in Italy 35
Development of immunoisolated cells implants for locoregional therapy in a colorectal cancer preclinical model 35
Immunomodulazione e infezioni:presente e futuro 35
Smoking 35
Evaluation of effect of Eucaliptus essential oil on macrophage phagocytic activity by confocal laser scanning microscopy and cytofluorimetric analysis. 34
Combination Therapy of cancer. Experimental Models 34
Antitumoral immunogenic peptides and vaccine thereof 34
THYMOSIN a1 IN COMBINATION WITH CYTOKINES AND CHEMOTHERAPY FOR THE TREATMENT OF CANCER. 34
NERVE GROWTH FACTOR: NEUROTROPHIN OR CYTOKINE? 34
In vivo up-regulation of the molecular target in a pre-clinical model metastatic colorectal cancer vaccine. AACR-NCI-EORTC 33
In vitro and in vivo effects of SCV-07 in a murine B16 melanoma model. 33
Nanosized cancer polymarker biochip - Laboratorio per la progettazione, produzione e validazione di biosensori optoe chemo-elettronici dedicati al rilevamento simultaneo di biomarkers associati a patologie tumorali 33
Efficacy of repeated cycles of chemo-immunotherapy with thymosin alpha1 and interleukin-2 after intraperitoneal 5-fluorouracil delivery. 33
Immunoisolated cells implants: from xenotrasplantation to locoregional chemo-immunotherapy through microfabricated biocapsules. 33
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 33
Ta1 up-regulates tumor antigen expression in colorectal cancer cells 32
Preclinical model of colorectal cancer vaccine: a model for combined approach 32
Identification of a new possible molecolar target for lung cancer: CSH-275 nonpeptide epitope. 32
Proposte Per Indirizzare Le Scelte Europee e Nazionali 31
Le Epatiti virali croniche: problemi di prevenzione e terapia in Puglia nella nuova realtà delle immigrazioni di massa 31
Differentiation of human melanoma cells induced by cyanidin-3-O-beta-glucopyranoside. 31
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 31
Anti-tumor effect of combined treatment with thymosin alpha 1 and interleukin-2 after 5-fluorouracil in liver metastases from colorectal cancer in rats. 31
Early detection of molecular markers suitable for colorectal diagnosis and therapy in carcinogenesis model 30
Sviluppo di un protocollo preclinico di immunizzazione genetica verso un antigene tumore-associato del colon 30
Induction of apoptosis in neoplastic cells by anthracycline antitumor drugs: nuclear and cytoplasmic triggering? 29
Ricerca Farmaceutica 29
Analysis of Melan-A/MART-1 antigen expression during differentiation induced by Cyanidin-3-O-B glucopyranoside in human melanoma cells 29
Combined treatment with thymosin-alpha1 and low dose interferon-alpha after dacarbazine in advanced melanoma. 29
Impact of the Gut Microflora on the development of Allergy 28
Risposta immunitaria dell'ospite eventi cellulari e variabilità virale nell'infezione da HCV 28
Impact of the Gut Microflora on the development of Allergy 28
Impact of the Gut Microflora on the development of Allergy 28
Timosina Alfa attiva i ricettori toll-like in risposta ad Asperglillus Fumigatus 28
Determinazione della specificità della risposta CTL verso TAA/TSA human shared in seguito a trattamento chemio-immunoterapico 27
Modificazioni farmacologiche di TAA/TSA e risposta CTL in adenocarcinoma colorettale 27
Up-regulation of Melan-A/MART-1 antigen expression during human melanoma cell differentiation. 26
In vitro activation of infectious herv K: Implication in melanoma progression 25
Il sistema Sanitario e la possibilità di collaborazione con il Venezuela 24
Ruolo di nuovi marcatori biomolecolari dell'epatocarcinoma su cirrosi, in relazione all'efficacia dei diversi approcci terapeutici 23
PRECLINICAL MODEL OF COLORECTAL CANCER VACCINE: A MODEL FOR A COMBINED APPROACH. 20
Totale 3.324
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.573
article - articoli 4.183
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.756
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202430 0 0 0 0 0 0 0 0 2 3 23 2
2024/20251.279 6 6 64 61 442 90 3 51 24 46 256 230
2025/20261.698 92 183 190 282 295 41 244 88 113 96 45 29
2026/2027317 70 82 165 0 0 0 0 0 0 0 0 0
Totale 3.324